Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

SMART-PANC: SMAD4 Tailored Neoadjuvant Therapy for Pancreatic Cancer, A Phase ll Non-Randomized, Single Center Pilot Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07748611
Title field or adapter rule
{'original_value': 'SMART-PANC: SMAD4 Tailored Neoadjuvant Therapy for Pancreatic Cancer, A Phase ll Non-Randomized, Single Center Pilot Study', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:21.553621+00:00
Published At
2026-10-29T00:00:00+00:00
Record Updated At
2026-10-29
Source Retrieved At
2026-10-31T22:17:25.750886+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Borderline Resectable Pancreatic Ductal Adenocarcinoma", "Resectable Pancreatic Ductal Adenocarcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-29", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07748611"
protocolSection.identificationModule.officialTitle
"SMART-PANC: SMAD4 Tailored Neoadjuvant Therapy for Pancreatic Cancer, A Phase ll Non-Randomized, Single Center Pilot Study"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Borderline Resectable Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Resectable Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Cohort A (gemcitabine, nab-paclitaxel)', 'Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Undergo blood sample collection', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort A (gemcitabine, nab-paclitaxel)', 'Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Undergo CT', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort A (gemcitabine, nab-paclitaxel)', 'Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Ancillary studies', 'name': 'Electronic Health Record Review', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Given fluorouracil', 'name': 'Fluorouracil', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort A (gemcitabine, nab-paclitaxel)', 'Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Given gemcitabine', 'name': 'Gemcitabine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Given irinotecan', 'name': 'Irinotecan', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Given leucovorin', 'name': 'Leucovorin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort A (gemcitabine, nab-paclitaxel)', 'Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Undergo MRI', 'name': 'Magnetic Resonance Imaging', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort A (gemcitabine, nab-paclitaxel)', 'Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Given nab-paclitaxel', 'name': 'Nab-paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Given oxaliplatin', 'name': 'Oxaliplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort A (gemcitabine, nab-paclitaxel)', 'Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Undergo radiation therapy', 'name': 'Radiation Therapy', 'type': 'RADIATION'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort A (gemcitabine, nab-paclitaxel)', 'Cohort B (gemcitabine, nab-paclitaxel or FOLFIRINOX)'], 'description': 'Undergo surgical resection', 'name': 'Surgical Procedure', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Fluorouracil (protocolSection.armsInterventionsModule.interventions[].name)
  • Gemcitabine (protocolSection.armsInterventionsModule.interventions[].name)
  • Irinotecan (protocolSection.armsInterventionsModule.interventions[].name)
  • Leucovorin (protocolSection.armsInterventionsModule.interventions[].name)
  • Nab-paclitaxel (protocolSection.armsInterventionsModule.interventions[].name)
  • Oxaliplatin (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.